LivaNova plc Aktie
45,20 €
Deine Einschätzung
LivaNova plc Aktie
Was spricht für und gegen LivaNova plc in den nächsten Jahren?
Pro
Kontra
Rendite von LivaNova plc im Vergleich
Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
---|---|---|---|---|---|---|---|
LivaNova plc | - | 6,60 % | 10,24 % | -14,72 % | -3,42 % | -35,89 % | -36,78 % |
Neogen Corp. | 0,68 % | 8,57 % | 2,01 % | - | - | - | - |
Bio-Rad Labs Inc. A | 0,49 % | 6,26 % | 4,89 % | -8,50 % | 5,21 % | -54,24 % | 0,34 % |
Merit Medical Systems | - | 0,00 % | 6,75 % | 38,10 % | 27,94 % | 43,80 % | 218,80 % |
Kommentare
News
LivaNova to Present at the Baird Global Healthcare Conference
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced Vladimir Makatsaria, Chief Executive Officer, will present in a fireside chat at the Baird 2024 Global
LivaNova Reports Second-Quarter 2024 Results
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today reported results for the quarter ended June 30, 2024 and raised full-year 2024 revenue and adjusted diluted earnings
LivaNova to Announce Second-Quarter 2024 Results
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its second-quarter 2024 results on Wednesday, July 31, 2024 at 1 p.m. London time (8